Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Caribou Biosciences
Biotech
Caribou boosts case for off-the-shelf CAR-T v. autologous
Caribou reported 17.1-month PFS, adding to evidence that the off-the-shelf treatment can match the efficacy of autologous products in lymphoma.
Nick Paul Taylor
Jun 11, 2026 8:00am
Allogeneic CAR-T biotechs fight to escape 'nuclear winter'
Feb 11, 2026 11:00am
Appeals court reignites row over CRISPR discovery
May 13, 2025 8:00am
Caribou cuts 32% of staff, further purges cell therapy pipeline
Apr 24, 2025 9:55pm
Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders
Jan 3, 2025 8:30am
CRISPR-focused Caribou christens new CMO—Chutes & Ladders
Aug 16, 2024 8:30am
